arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

GoodRx Holdings, Inc.

GDRX
$3.49 ▼ -0.22 (-5.93%) at close
Technology ·Services-Computer Processing & Data Preparation ·USServices-Computer Processing & Data Preparation
32 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
60
Health
Fair
Neutral
auto_awesome

Analytical Summary

GoodRx Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Technology sector before making investment decisions.

Market Cap $1.2B
Dividend Yield —
Revenue Growth -1.3% ↗
Op. Margin 11.8% ↗
ROIC 1.2% ↗
FCF / Share $0.24 ↗
Trailing P/E 116.3x
Price / Book 1.8x
FCF Yield 6.8%
Debt / Equity 0.74
info Valuation on last close. End-of-day price, Nov 5, 2026.

32-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$200.41M
↓ -1.3% —
Net Income Profit after all expenses
$1.17M
↓ -89.4% —
Operating Margin Operating profit as % of sales
11.8%
↑ +63.3% 59th
FCF / Share Free cash flow per share
$0.24
↑ +654.7% —
Long-Term Debt Long-term obligations
$481.59M
— -0.2% —

Health Breakdown

Profitability →
62
Returns
54
Financial Health ↑
48
Cash Quality
96

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 9 years · 32 quarters